Cargando…
Pharmacokinetic and Metabolomic Studies with BIO 300, a Nanosuspension of Genistein, in a Nonhuman Primate Model
Genistein is a naturally occurring phytoestrogen isoflavone and is the active drug ingredient in BIO 300, a radiation countermeasure under advanced development for acute radiation syndrome (H-ARS) and for the delayed effects of acute radiation exposure (DEARE). Here we have assessed the pharmacokine...
Autores principales: | Cheema, Amrita K., Mehta, Khyati Y., Santiago, Paola T., Fatanmi, Oluseyi O., Kaytor, Michael D., Singh, Vijay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429499/ https://www.ncbi.nlm.nih.gov/pubmed/30870965 http://dx.doi.org/10.3390/ijms20051231 |
Ejemplares similares
-
Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates
por: Li, Yaoxiang, et al.
Publicado: (2022) -
Comparative proteomic analysis of serum from nonhuman primates administered BIO 300: a promising radiation countermeasure
por: Girgis, Michael, et al.
Publicado: (2020) -
Metabolomic Studies of Tissue Injury in Nonhuman Primates Exposed to Gamma-Radiation
por: Cheema, Amrita K., et al.
Publicado: (2019) -
A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol
por: Cheema, Amrita K., et al.
Publicado: (2017) -
Plasma Derived Exosomal Biomarkers of Exposure to Ionizing Radiation in Nonhuman Primates
por: Cheema, Amrita K., et al.
Publicado: (2018)